Vontobel Holding’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.51M Buy
+152,500
New +$8.28M 0.02% 393
2026
Q1
Sell
-47,800
Closed -$4.56M 1240
2025
Q4
$4.56M Buy
47,800
+20,800
+77% +$2.04M 0.01% 408
2025
Q3
$2.64M Buy
27,000
+12,000
+80% +$1.24M 0.01% 499
2025
Q2
$1.61M Buy
+15,000
New +$1.52M 0.01% 559

Other funds holding BSX

Vontobel Holding's BSX Position: Q2 2026 in Review

Vontobel Holding reduced its Boston Scientific (BSX) stake by 39% in Q2 2026, selling an estimated $169M and leaving 4,871,518 shares worth $208M. The position accounts for 0.66% of the portfolio, ranked #35.

Vontobel Holding first reported a position in BSX in Q4 2020 and has held it in 23 quarters since. The position peaked at $645M in Q2 2024. 1,482 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Vontobel Holding held 4,871,518 shares of Boston Scientific worth $208M as of Q2 2026.
  • Vontobel Holding sold 3,106,696 Boston Scientific shares in Q2 2026, an estimated $169M.
  • Boston Scientific made up 0.66% of Vontobel Holding's portfolio in Q2 2026, its #35 holding.
  • Vontobel Holding first reported a position in Boston Scientific in Q4 2020 and has held it in 23 quarters since.
  • Vontobel Holding's Boston Scientific position peaked at $645M in Q2 2024.
  • 1,482 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Vontobel Holding's 13F filing for Q2 2026, filed 3 Aug 2026.